Investing Profile

Kazumi Shiosaki

VC
Photo of Kazumi Shiosaki, Managing Partner at MPM Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
UC Berkeley Network
42 CONNECTIONS
cb
MPM Capital Managing Partner
4
$100M
CompanyStageDateRound SizeTotal Raised
Twentyeight-Seven Therapeutics
Series AMay 2019$15M
Series ASep 2018$65M
Series AApr 2016
$80M
Co-investors: Henrijette Richter (Soffinova Partners)
Epizyme
Series BOct 2009$32M
$40M
Co-investors: Beth Seidenberg (Westlake Village BioPartners), David Mott (Mott Family Capital)
Managing Director MPM CapitalPresent
CEO Epizyme2007 - 2010
CEO Primera2004 - 2006
SVP Drug Discovery Millennium Pharmaceuticals1997 - 2001
UC Berkeley PhD Synthetic Chemistry